The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse

被引:191
|
作者
Tate, P
Skarnes, W
Bird, A
机构
[1] UNIV EDINBURGH,INST CELL & MOLEC BIOL,EDINBURGH EH9 3JR,MIDLOTHIAN,SCOTLAND
[2] UNIV EDINBURGH,BBSRC CTR GENOME RES,EDINBURGH EH9 3JQ,MIDLOTHIAN,SCOTLAND
关键词
D O I
10.1038/ng0296-205
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Vertebrate genomes are heavily methylated at cytosines in the sequence CpG. The biological role of this modification is probably mediated by DNA binding proteins that are either attracted to or repelled by methyl-CpG1. MeCP2 is an abundant chromosomal protein that binds specifically to methylated DNA in vitro, and depends upon methyl-CpG for its chromosomal distribution in vivo. To assess the functional significance of MeCP2, the X- linked gene was mutated in male mouse embryonic stem (ES) cells using a promoterless gene-targeting construct containing a lacZ reporter gene. Mutant ES cells lacking MeCP2 grew with the same vigour as the parental line and were capable of considerable differentiation. Chimaeric embryos derived from several independent mutant lines, however, exhibited developmental defects whose severity was positively correlated with the contribution of mutant cells. The results demonstrate that MeCP2, like DNA methyltransferase, is dispensable in stem cells, but essential for embryonic development.
引用
收藏
页码:205 / 208
页数:4
相关论文
共 50 条
  • [31] Early life stress exacerbates behavioural and neuronal alterations in adolescent male mice lacking methyl-CpG binding protein 2 (Mecp2)
    Torres-Perez, Jose Vicente
    Martinez-Rodriguez, Elena
    Forte, Anabel
    Blanco-Gomez, Carlos
    Stork, Oliver
    Lanuza, Enrique
    Santos, Monica
    Agustin-Pavon, Carmen
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2022, 16
  • [32] Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver
    Esfandiari, F
    Green, R
    Cotterman, RF
    Pogribny, IP
    James, SJ
    Miller, JW
    CARCINOGENESIS, 2003, 24 (12) : 1935 - 1940
  • [33] Overexpression of methyl-CpG-binding protein 2 and autoimmunity: evidence from MECP2 duplication syndrome, lupus, MECP2 transgenic and Mecp2 deficient mice
    Sawalha, A. H.
    LUPUS, 2013, 22 (09) : 870 - 872
  • [34] Investigation of the interaction between MeCP2 methyl-CpG binding domain and methylated DNA by single molecule force spectroscopy
    Qin, Juan
    Zhang, Miaomiao
    Guan, Yanxue
    Li, Chen
    Ma, Xingxing
    Rankl, Christian
    Tang, Jilin
    ANALYTICA CHIMICA ACTA, 2020, 1124 : 52 - 59
  • [35] Methyl-CpG Binding Protein 2 in Alzheimer Dementia
    Kim, Baeksun
    Choi, Yunjung
    Kim, Hye-Sun
    Im, Heh-In
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2019, 23 : S72 - S81
  • [36] Modulation of VEGF transcription by CpG-methyl CpG binding protein-2 (MeCP2) interactions.
    Lapchak, PH
    Pal, S
    Melter, M
    Mukhopadhyay, D
    Briscoe, DM
    FASEB JOURNAL, 2002, 16 (04): : A214 - A214
  • [37] Expression of nuclear Methyl-CpG binding protein 2 (Mecp2) is dependent on neuronal stimulation and application of Insulin-like growth factor 1
    Tropea, Daniela
    Mortimer, Niall
    Bellini, Stefania
    Molinos, Ines
    Sanfeliu, Albert
    Shovlin, Stephen
    McAllister, Donna
    Gill, Michael
    Mitchell, Kevin
    Corvin, Aiden
    NEUROSCIENCE LETTERS, 2016, 621 : 111 - 116
  • [38] Tight interaction between densely methylated DNA fragments and the methyl-CpG binding domain of the rat MeCP2 protein attached to a solid support
    Shiraishi, M
    Sekiguchi, A
    Chuu, YH
    Sekiya, T
    BIOLOGICAL CHEMISTRY, 1999, 380 (09) : 1127 - 1131
  • [39] The methyl-CpG- binding protein MECP2 is required for prostate cancer cell growth
    Bernard, D
    Gil, J
    Dumont, P
    Rizzo, S
    Monté, D
    Quatannens, B
    Hudson, D
    Visakorpi, T
    Fuks, F
    de Launoit, Y
    ONCOGENE, 2006, 25 (09) : 1358 - 1366
  • [40] The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth
    D Bernard
    J Gil
    P Dumont
    S Rizzo
    D Monté
    B Quatannens
    D Hudson
    T Visakorpi
    F Fuks
    Y de Launoit
    Oncogene, 2006, 25 : 1358 - 1366